WJ460
CAS No. 1415251-36-3
WJ460 ( —— )
Catalog No. M26864 CAS No. 1415251-36-3
WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 129 | Get Quote |
|
10MG | 219 | Get Quote |
|
25MG | 357 | Get Quote |
|
50MG | 537 | Get Quote |
|
100MG | 781 | Get Quote |
|
500MG | 1593 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameWJ460
-
NoteResearch use only, not for human use.
-
Brief DescriptionWJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.
-
DescriptionWJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.(In Vitro):WJ460 dose-dependently blocks breast cancer cell invasion through Collagen I(IC50: 43.37?nM in MDA-MB-231 and 36.40 nM in BT549 cells).(In Vivo):In a spontaneous metastasis model, WJ460 inhibits angiogenesis, breast tumor growth, and spontaneous metastasis .
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorAdrenocorticotropic hormone (ACTH)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1415251-36-3
-
Formula Weight460.6
-
Molecular FormulaC27H28N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NCCCCC=1C=CC=CC1)C2=CC=CC(=C2)C3SCC(=O)N3C=4C=CC=CC4OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Francesco Iuliano, et al. Adding Slow Release Tetracosactide Acetate to Eltrombopag Improves Haematological Response in ITP Patients with Platelet-Count Fluctuation.
molnova catalog
related products
-
Scutebarbatine B
Scutebarbatine B shows weak cytotoxicity with IC50 values ranging from 35.11 to 42.73 μM against K562 cell lines and HL60 cell lines.
-
Rilmenidine Phosphat...
Rilmenidine Phosphate is a selective I(1) imidazoline receptor agonist, used to treat hypertension.
-
DSR-6434
DSR-6434 has a strong antitumor effect. DSR-6434 is a potent and selective Toll-like receptor 7 (TLR7) agonist, with EC50s of 7.2 nM and 4.6 nM for human and mice TLR7, respectively.